Intraperitoneal IL-6 signaling in incident patients treated with icodextrin and glucose bicarbonate/lactate-based peritoneal dialysis solutions

Abstract

Higher levels of IL-6, its soluble receptors, and leukocyte expression were observed in icodextrin-treated peritoneal dialysis patients, but this difference was not associated with alterations in peritoneal permeability or systemic inflammation during 1 year of follow-up.

Keywords

• biocompatibility
• glycoprotein 130
• icodextrin
• interleukin 6
• interleukin 6 receptor
• peritoneal dialysis solution